After meeting with the FDA, biopharmaceuticals company Alterity Therapeutics (ASX: ATH) has confirmed Phase II clinical trial plans for their…
Following preliminary eco-toxicity studies on limited aquatic species, agtech developer Bio-Gene Technology (ASX: BGT) has reported favourable results for its…
3D printing medtech company Osteopore (ASX: OSX) is set to continue their successful streak, following news that the company has…
Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases…
Australian biopharmaceuticals developer Neuren Pharmaceuticals (ASX: NEU) has been granted a patent from the European Patent Office covering NNZ-2591, a…
Carried and administered by Australian paramedics for decades, the green whistle pain reliever has been on the Australian market for…